ArticleEndoscopy international open2026
Endoscopic ultrasound-directed transenteric ERCP in patients with benign and malignant diseases and inaccessible biliary system.
Article in Endoscopy international open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and study aims: Patients requiring biliary interventions with endoscopically inaccessible papilla or biliodigestive anastomosis represent a challenge in clinical practice. Historically, percutaneous transhepatic biliary drainage (PTBD) has often been the only viable treatment after failed endoscopic attempts. Recently, endoscopic ultrasound (EUS)-guided techniques have emerged as promising alternatives. This study evaluated the feasibility and safety of EUS-guided transenteric ERCP (EDEE) at a tertiary referral center. Patients and methods: This retrospective, single-center study included patients who underwent EDEE between February 2020 and November 2025. Primary endpoints were safety and overall technical success, defined as successful creation of an EUS-guided anastomosis (EA) using a lumen-apposing metal stent (LAMS) followed by endoscopic retrograce cholangiopancreatography (ERCP) via LAMS. Secondary endpoints included clinical success, need for reinterventions, and procedure characteristics. Results: A total of 24 patients (70.3 ± 12.6 years; 6 female) were analyzed. Sixteen patients had surgically altered anatomy (5 Whipple, 11 Roux-en-Y), and eight presented with malignant gastric outlet obstruction. EA and ERCP via LAMS were conducted in two stages with a median interval of 29.5 days. In 15 patients, the afferent loop was accessed after filling via a previously placed PTBD, which was removed after EDEE. Technical success was 100% (24/24) for EA and 87.5% (21/24) for ERCP via LAMS; overall technical and clinical success were 87.5% (21/24). Procedure-related complications occurred in two patients (8.3%), including one aspiration pneumonia and one LAMS misplacement. Conclusions: This study suggests that EDEE is a feasible and safe method for biliary drainage in patients with inaccessible biliary anatomy, demonstrating high technical and clinical success in both malignant and benign conditions being performed at a highly specialized tertiary center.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.